Incyte Corporation INCY
Set alert
120.04 USD -0.35 -0.29%
At close · Nov 2
120.04 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
118.25 Day range 121.52
90.30 52-week range 129.93
- YTD
- +21.53%
- 1 year
- +28.41%
- Open
- 119.02
- Prev close
- 120.39
- Mkt cap
- 24.47B
- Vol
- 1.75M
- Avg vol
- 1.61M
- EPS
- 1.95
- P/E
- 61.56
- Div yield
- 0.00%
More statistics
- Low
- 118.25
- High
- 121.52
- Forward P/E
- 13.86
- Beta
- 0.78
- Short ratio
- 5.61
- Inst. own
- 103.61%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 9, 2027
- 50-d avg
- 120.49
- 200-d avg
- 108.06
- 1y target
- 130.92
Analyst view
Consensus: buy
Buy
Price target (mean) 130.92 +9.1% upside
Now 120.04
- Target (low)
- 86.00
- Target (mean)
- 130.92
- Target (high)
- 157.00
Ratings (0m) 28 13 buy · 14 hold · 1 sell
- Strong buy2
- Buy11
- Hold14
- Sell1
- Strong sell0
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.01 | 1.69 – 3.08 | 1.80 | +11.7% | 1.56B | +3.3% | 15 |
| Next quarter | 1.77 | 1.15 – 1.95 | 1.81 | -2.4% | 1.35B | +5.7% | 5 |
| Current year | 3.49 | 2.76 – 4.38 | 6.80 | -48.7% | 6.04B | +17.4% | 16 |
| Next year | 8.78 | 7.34 – 9.95 | 3.49 | +151.5% | 6.28B | +4.0% | 19 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| Oct 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Oct 30, 2026 | Oppenheimer | Upgrade | Perform | Outperform |
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 14, 2026 | Truist Securities | Maintained | Hold | Hold |
| Oct 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 5, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Sep 28, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Sep 28, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 22, 2026 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Aug 20, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Aug 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 17, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 3, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 3, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 29, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 29, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Jul 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 29, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 23, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 23, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 21, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 14, 2026 | Barclays | Maintained | Overweight | Overweight |
